October 5, 2017
Reliq Health Technologies Reaches First Major Milestone of 1,000 Patients Live on Its Remote Patient Monitoring and Telemedicine Platform
VANCOUVER, British Columbia, Oct. 05, 2017 (GLOBE NEWSWIRE) — Reliq Health Technologies Inc. (TSX VENTURE:RHT) (OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce that it now has 1,000 paid subscribers using its chronic care management, remote patient monitoring and telemedicine solution, representing recurring monthly revenue of US$50,000/month.
“We are excited to announce that we now have 1,000 patients live on our platform,” said Dr. Lisa Crossley, CEO of Reliq Health. “This is a critical milestone for Reliq as we move forward with our roll out to over 40,000 patients in accordance with our previously-announced contracts with Paz Home Health, LLC (Pharr, TX) and Rio Grande Valley Health Alliance, LLC (McAllen, TX). We expect to enroll at least 1,000 new patients per month through 2018 with these two contracts, which together are worth over US$26 Million annually in recurring revenue at full deployment.”
Reliq’s digital health solution provides high quality virtual care in the community by creating a “virtual hospital ward” within the patient’s home, automatically collecting vital signs and tracking medication adherence. Reliq’s interactive voice technology provides patients with audible alerts and reminders to take their medications, collect their vitals using Bluetooth-enabled monitoring devices and perform prescribed rehab or fitness activities. Reliq’s two-way voice hub provides voice-activated access to patient education content, empowering patients and family members to proactively manage complex chronic conditions. The Reliq Health cloud platform instantly alerts the clinical care team if a patient develops key warning signs, allowing clinicians to intervene before a health crisis occurs and preventing costly and disruptive hospital readmissions and ER visits.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
Back to the main Media Room page, or press the Back button on your browser.